Sees Q3 adjusted EBITDA $3M-$4M. “WorkSimpli’s performance during the quarter was pressured by an unexpectedly challenging advertising environment for its products and executional issues, which have since been addressed by their leadership. Based on its current operational performance and following recent strategic efforts, we expect WorkSimpli’s financial results to improve in the second half of the year, and to return to peak profitability by year-end 2024 on a monthly run-rate basis with significant growth in 2025. While we remain confident in our ability to monetize this non-core asset, we expect our core telehealth business will be the driving force of long-term growth in revenue and profitability,” he added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFMD:
- LifeMD to Report Second Quarter 2024 Financial Results on August 7
- LifeMD price target lowered to $10 from $12 at KeyBanc
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
- LifeMD launches private health insurance acceptance for primary care services
- LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit
Questions or Comments about the article? Write to editor@tipranks.com